Our previous study demonstrated that the acetylcholine (Ach)/CHRNA5 axis promotes PNI progression in cholangiocarcinoma by upregulating BDNF expression through activation of the CAMKII/GSK3β/β‐catenin signaling pathway [12]. This evidence concerns the gene CHRNA5 and cholangiocarcinoma.